ACA
SPPI

Avoro Capital Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Avoro Capital Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,419,818
Closed -$71.7M – 50
2018
Q2 		$71.7M Buy
+3,419,818
New +$63.4M 2.76% 12
2015
Q4 		– Sell
-1,315,600
Closed -$7.87M – 34
2015
Q3 		$7.87M Buy
+1,315,600
New +$9.13M 2.05% 16

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Avoro Capital Advisors's SPPI Position: Q3 2018 in Review

Avoro Capital Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2018, closing a stake of 3,419,818 shares — an estimated $71.7M sold.

Avoro Capital Advisors first reported a position in SPPI in Q3 2015 and held it in 2 quarters. The position peaked at $71.7M in Q2 2018. 190 funds tracked by Wall St. Rank hold SPPI as of Q3 2018.

  • Avoro Capital Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • Avoro Capital Advisors sold 3,419,818 Spectrum Pharmaceuticals Inc shares in Q3 2018, an estimated $71.7M.
  • Avoro Capital Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q3 2015 and held it in 2 quarters.
  • Avoro Capital Advisors's Spectrum Pharmaceuticals Inc position peaked at $71.7M in Q2 2018.
  • 190 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2018.

Based on Avoro Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.